Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel Warren

8PUBLICATIONS
31CO-AUTHORS
Access to justiceChemotherapyPredictive and prognostic markersTransplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Dec 15, 2025
A Two-Center Randomized Controlled Trial to Assess Financial Incentives for Compliance With Living Kidney Donor Follow-Up in the United States.

Shivani S Bisen, Tanveen Ishaque, Alvin G Thomas

|Nov 27, 2023
Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial.

Niraj M Desai, Sherry G Leung, Jennifer D Motter

|Jan 18, 2023
Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk.

Jennifer L Alejo, Jake D Kim, Teresa P Y Chiang

|Nov 28, 2022
6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipients.

Jonathan Mitchell, Teresa Py Chiang, Jennifer L Alejo

|Sep 08, 2022
Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipients.

Jennifer L Alejo, Jessica M Ruck, Teresa P Y Chiang

|Jun 07, 2022
Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses.

Amy Chang, Teresa Py Chiang, Jake D Kim

Pageof 2

Frequent Collaborators

8 joint publications

Dorry L Segev

7 joint publications

Allan B Massie

6 joint publications

Teresa Py Chiang

6 joint publications

Jennifer L Alejo

6 joint publications

William A Werbel

6 joint publications

Jake D Kim

6 joint publications

Robin K Avery

5 joint publications

Macey L Levan

5 joint publications

Jacqueline M Garonzik-Wang

5 joint publications

Aaron A R Tobian

Frequent Collaborators

8 joint publications

Dorry L Segev

7 joint publications

Allan B Massie

6 joint publications

Teresa Py Chiang

6 joint publications

Jennifer L Alejo

Top Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on : Apr 12, 2021

4.9K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on : May 02, 2013

16.1K
<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on : Aug 12, 2017

14.4K
See more related videos

Top Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on : Apr 12, 2021

4.9K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on : May 02, 2013

16.1K
<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

<em>In Vitro</em> and <em>In Vivo</em> Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on : Aug 12, 2017

14.4K
See more related videos